Cong Shen

Cong Shen


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2023 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
HCHou Yee Choo
Hou Yee Choo
JWJunJie Wee
JunJie Wee
CSCong Shen
Cong Shen
KXKelin Xia
Kelin Xia

1 December 2020 in Bioinformatics
Verified
Journal Article
Closed access
CSCong Shen
Cong Shen
JLJiawei Luo
Jiawei Luo
WOWenjue Ouyang
Wenjue Ouyang
PDPingjian Ding
Pingjian Ding
XCXiangtao Chen
Xiangtao Chen
Motivation: Protein kinases have been the focus of drug discovery research for many years because they play a causal role in many human diseases. Understanding the binding profile of kinase inhibitors is a prerequisite for drug discovery, and traditional methods of predicting kinase inhibitors are time-consuming and inefficient. Calculation-based predictive methods provide a relatively low-cost and high-efficiency approach to the rapid development and effective understanding of the binding profile of kinase inhibitors. Particularly, the continuous improvement of network pharmacology methods provides unprecedented opportunities for drug discovery, network-based computational methods could be employed to aggregate the effective information from heterogeneous sources, which have become a new way for predicting the binding profile of kinase inhibitors. Results: In this study, we proposed a network-based influence deep diffusion model, named IDDkin, for enhancing the prediction of kinase inhibitors. IDDkin uses deep graph convolutional networks, graph attention networks and adaptive weighting methods to diffuse the effective information of heterogeneous networks. The updated kinase and compound representations are used to predict potential compound-kinase pairs. The experimental results show that the performance of IDDkin is superior to the comparison methods, including the state-of-the-art kinase inhibitor prediction method and the classic model widely used in relationship prediction. In experiments conducted to verify its generalizability and in case studies, the IDDkin model also shows excellent performance. All of these results demonstrate the powerful predictive ability of the IDDkin model in the field of kinase inhibitors. Availability and implementation: Source code and data can be downloaded from https://github.com/CS-BIO/IDDkin. Supplementary information: Supplementary data are available at Bioinformatics online.

10 July 2020 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
CSCong Shen
Cong Shen
JLJiawei Luo
Jiawei Luo
ZLZihan Lai
Zihan Lai
PDPingjian Ding
Pingjian Ding

24 February 2020 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
JLJiawei Luo
Jiawei Luo
CSCong Shen
Cong Shen
ZLZihan Lai
Zihan Lai
JCJie Cai
Jie Cai
PDPingjian Ding
Pingjian Ding
Small molecule(SM) drugs can affect the expression of miRNAs, which plays crucial roles in many important biological processes. The chemical structure and clinical information of small molecule can simultaneously incorporate information such as anatomical distribution, therapeutic effects and structural characteristics. It is necessary to develop a novel model that incorporates small molecule chemical structure and clinical information to reveal the unknown small molecule-miRNA associations. In this study, we developed a new framework based on non-negative matrix factorization, called SMANMF, to discover the potential small molecules-miRNAs associations. First, the functional similarity of two miRNAs can be obtained by computing the overlap of the target gene sets in which the miRNAs interact together, and we integrated two types of small molecule similarities, including chemical similarity and clinical similarity. Then, we utilized a non-negative matrix factorization model to discover the unknown relationship between small molecules and miRNAs. The evaluation results indicate that our model can achieve superior prediction performance compared with previous approaches in 5-fold cross-validation. At the same time, the results of case studies also reveal that the SMANMF model has good predictive performance for predicting the potential association between small molecules and miRNAs.

3 September 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
ZJZhenyu Jiang
Zhenyu Jiang
PDPingjian Ding
Pingjian Ding
CSCong Shen
Cong Shen
XDXiaopeng Dai
Xiaopeng Dai
Drug-drug interaction (DDI) can trigger many adverse effects in patients and has emerged as a threat to medicine and public health. Therefore, it is important to predict potential drug interactions since it can provide combination strategies of drugs for systematic and effective treatment. Existing deep learning-based methods often rely on DDI functional networks, or use them as an important part of the model information source. However, it is difficult to discover the interactions of a new drug. To address the above limitations, we propose a geometric molecular graph representation learning model (Mol-DDI) for DDI prediction based on the basic assumption that structure determines function. Mol-DDI only considers the covalent and non-covalent bond information of molecules, then it uses the pre-training idea of large-scale models to learn drug molecular representations and predict drug interactions during the fine-tuning process. Experimental results show that the Mol-DDI model outperforms others on the three datasets and performs better in predicting new drug interaction experiments.

17 June 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZJZhenyu Jiang
Zhenyu Jiang
ZGZhi Gong
Zhi Gong
ZJZhenyu Jiang
Zhenyu Jiang
HZHongyan Zhang
Hongyan Zhang
PDPingjian Ding
Pingjian Ding
CSCong Shen
Cong Shen
Drug-drug interaction (DDI) is the combined effects of multiple drugs taken together, which can either enhance or reduce each other’s efficacy. Thus, drug interaction analysis plays an important role in improving treatment effectiveness and patient safety. It has become a new challenge to use computational methods to accelerate drug interaction time and reduce its cost-effectiveness. The existing methods often do not fully explore the relationship between the structural information and the functional information of drug molecules, resulting in low prediction accuracy for drug interactions, poor generalization, and other issues. In this paper, we propose a novel method, which is a deep graph contrastive learning model for drug-drug interaction prediction (DeepGCL for brevity). DeepGCL incorporates a contrastive learning component to enhance the consistency of information between different views (molecular structure and interaction network), which means that the DeepGCL model predicts drug interactions by integrating molecular structure features and interaction network topology features. Experimental results show that DeepGCL achieves better performance than other methods in all datasets. Moreover, we conducted many experiments to analyze the necessity of each component of the model and the robustness of the model, which also showed promising results. The source code of DeepGCL is freely available athttps://github.com/jzysj/DeepGCL.